Grant: Master's Award: Canada Graduate Scholarships
University of Alberta
$17,500.00
SARS-CoV2 Proteins Alter the Mitochondria-Associated Membrane, a Structure that Controls Neuroinflammation
FY 2020-21
Summary
The 2019 coronavirus disease (COVID-19) is an infectious disease, where severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) infects cells of the airways. Additionally, coronaviruses are known to activate inflammatory signaling pathways and cause dysfunction of the brain (neuroinflammation). To address brain defects within COVID-19 patients, a better understanding of the consequences of SARS-CoV2 would be beneficial. The Simmen Lab has previously identified an intracellular structure known as the mitochondria-associated membrane (MAM) as a key control station of neuroinflammation. This structure controls the energy output of mitochondria, but also promotes inflammation. We hypothesized that COVID-19 could trigger the same effect, because several SARS-CoV2 proteins, including ORF8, are known to colocalize with MAM proteins. Indeed, preliminary results from the lab have indicated that SARS-CoV2-infected human cells show changes to the mitochondrial structures and have hallmarks of cell stress. I therefore hypothesize that a subset of SARS-CoV2 proteins compromise the control of mitochondria through the disruption of MAM proteins. To test this hypothesis, I will express SARS-CoV2 proteins in different human cells systems and observe the structure of MAM. Next, I will monitor cellular energy, stress levels, and inflammatory levels. Using different brain cell types, I will test whether response also occurs in these cells and whether it can be transmitted from one cell type to another, a frequent event during neuroinflammation.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
449470
Name
Mina Lucas
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
SARS-CoV2 Proteins Alter the Mitochondria-Associated Membrane, a Structure that Controls Neuroinflammation
Programtype2
Studentship Programs
Orgnameinp2
University of Alberta
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Covid-19; Endoplasmic Reticulum; Metabolism; Mitochondria; Mitochondria-Associated Membrane; Neuroinflammation; Orf8; Sars-Cov2
Abstract
The 2019 coronavirus disease (COVID-19) is an infectious disease, where severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) infects cells of the airways. Additionally, coronaviruses are known to activate inflammatory signaling pathways and cause dysfunction of the brain (neuroinflammation). To address brain defects within COVID-19 patients, a better understanding of the consequences of SARS-CoV2 would be beneficial. The Simmen Lab has previously identified an intracellular structure known as the mitochondria-associated membrane (MAM) as a key control station of neuroinflammation. This structure controls the energy output of mitochondria, but also promotes inflammation. We hypothesized that COVID-19 could trigger the same effect, because several SARS-CoV2 proteins, including ORF8, are known to colocalize with MAM proteins. Indeed, preliminary results from the lab have indicated that SARS-CoV2-infected human cells show changes to the mitochondrial structures and have hallmarks of cell stress. I therefore hypothesize that a subset of SARS-CoV2 proteins compromise the control of mitochondria through the disruption of MAM proteins. To test this hypothesis, I will express SARS-CoV2 proteins in different human cells systems and observe the structure of MAM. Next, I will monitor cellular energy, stress levels, and inflammatory levels. Using different brain cell types, I will test whether response also occurs in these cells and whether it can be transmitted from one cell type to another, a frequent event during neuroinflammation.
Competitiondate
202012
Approvedterm2
1 yr 0 mth
Pinamesdelim
Mina, Lucas
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~